ArticleThe Lancet. Oncology2015
SABR in early operable lung cancer: time for evidence.
Article in The Lancet. Oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Systematic lymphadenectomy versus sampling of ipsilateral mediastinal lymph-nodes during lobectomy for non-small-cell lung cancer: a systematic review of randomized trials and a meta-analysis.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2017Pooled it
- Surgery and stereotactic body radiotherapy for early-stage non-small cell lung cancer: prospective clinical trials of the past, the present, and the future.General thoracic and cardiovascular surgery · 2020Review
- Salvage Therapy for Locoregional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage NSCLC.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2020Review
- Treatment selection of early stage non-small cell lung cancer: the role of the patient in clinical decision making.BMC cancer · 2018Article
- Stage I lung cancer-to operate or to radiate? that is the question.Journal of thoracic disease · 2016Article
- Is surgery still the optimal treatment for stage I non-small cell lung cancer?Translational lung cancer research · 2016Review
- Cons: long-term CT-scan follow-up is not the standard of care in patients curatively treated for an early stage non-small cell lung cancer.Translational lung cancer research · 2015Article
- Improving lung cancer outcomes by improving the quality of surgical care.Translational lung cancer research · 2015Article
- [Stereotactic Ablative Radiotherapy for Operable Stage I Non-small Cell Lung Cancer in Clinical Practice: How Long Way to Go?].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2015Article
- Lung cancer specialists' opinions on treatment for stage I non-small cell lung cancer: A multidisciplinary survey.Advances in radiation oncologyArticle
Corrections and comments
- Commented on by
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
25981817What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.